We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Injectable Gel Could Replace Rinses in Cancer Treatment

By HospiMedica International staff writers
Posted on 14 May 2019
Print article
Image: An injectable ‘chemo gel’ could replace abdominal flushes (Photo courtesy of TU/e).
Image: An injectable ‘chemo gel’ could replace abdominal flushes (Photo courtesy of TU/e).
A novel hydrogel that can be injected into the abdominal cavity could deliver local chemotherapy for weeks, providing a better alternative to current abdominal rinses.

Developed at Eindhoven University of Technology (TU/e; The Netherlands), Academic Hospital Maastricht (UMC; The Netherlands), and Catharina Hospital (Eindhoven, The Netherlands), the new hydrogel is liquid during the injection phase, but is programmed to partly solidify after it is released into the body. The gel is packed with chemotherapy drugs that are slowly released over a period of days or even weeks. The researchers are now planning pre-clinical murine studies for a period of up to four years to examine efficacy and safety.

“This new treatment combines the advantage of local chemotherapy with a non-invasive, long-term administration method,” said Professor Patricia Dankers, PhD, of TU/e. “Patients who are not eligible for current forms of treatment are therefore likely to be able to receive treatment using this technique.”

“At the moment, the only promising treatment is an operation, in which the metastases are surgically removed, combined with a flush of local chemotherapy in which the abdominal cavity is rinsed for 90 minutes with chemo,” said Professor Ignace de Hingh, MD, PhD, of Catharina Hospital: “The effect of this flush is limited because of its short duration. In addition, a large group of patients (1 in 4) is not eligible for this treatment because they are considered insufficiently fit to undergo this severe treatment. The effect then does not sufficiently outweigh the distress suffered by the patient.”

Abdominal (or peritoneal) cancer is mainly caused by metastases of intestinal cancer, with one in eight patients with bowel cancer developing them in the abdominal cavity. At the moment, the only promising treatment is surgical excision followed by hyperthermic intra peritoneal chemotherapy (HIPEC).

Related Links:
University of Technology
Academic Hospital Maastricht
Catharina Hospital
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Baby Warmer
THERMOCARE Convenience

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more